Erratum to: Evaluation of a New Formulation of Epoprostenol Sodium in Japanese Patients with a Pulmonary Arterial Hypertension (EPITOME4)

Documenti analoghi

• Evaluation of a New Formulation of Epoprostenol Sodium in Japanese Patients with Pulmonary Arterial Hypertension (EPITOME4)
  di: Tamura, Yuichi, et al.
  Pubblicazione: (2013)
• Rapid Initiation of Intravenous Epoprostenol Infusion Is the Favored Option in Patients with Advanced Pulmonary Arterial Hypertension
  di: Kimura, Mai, et al.
  Pubblicazione: (2015)
• Arterial methemoglobin level predicts therapeutic effectiveness of the PDE5 inhibitors in patients with in idiopathic pulmonary arterial hypertension
  di: Tamura, Yuichi, et al.
  Pubblicazione: (2011)
• Temperature Variations around Medication Cassette and Carry Bag in Routine Use of Epoprostenol Administration in Healthy Volunteers
  di: Tamura, Yuichi, et al.
  Pubblicazione: (2012)
• Stability and preservation of a new formulation of epoprostenol sodium for treatment of pulmonary arterial hypertension
  di: Lambert, Olivier, et al.
  Pubblicazione: (2012)